OCT 05, 2022 8:53 AM PDT

Emergency Contraception Pills are Significantly Less Effective in People Who Are Overweight

WRITTEN BY: Zoe Michaud

Emergency contraception pills can be used to prevent pregnancy within 72 hours of having unprotected sex. When taken as directed, emergency contraception pills can reduce the risk of pregnancy by up to 87%. 

Emergency contraception pills (which go by brand names such as Plan B One Step, Take Action, and My Way) contain a hormone called levonorgestrel, which prevents pregnancy by preventing or delaying ovulation. Levonorgestrel only affects ovulation and will not end a pregnancy in a person who is already pregnant. These medications are generally safe but can cause side effects including nausea, abdominal pain, fatigue, and headache. 

Meta-analysis studies have shown that emergency contraception pills are ineffective in women above a certain body mass index (BMI) and weight. At the standard dose (1.5mg of levonorgestrel), emergency contraception pills begin to lose potency in women weighing 165 pounds. In women weighing 175 pounds or more, emergency contraception pills typically do not work at all. 

Since the average weight of a woman in the United States is around 166 pounds, this information is critical in informing individual and public health decisions. The copper intrauterine device (IUD) is an effective form of emergency contraception for women regardless of weight or BMI. The copper IUD successfully prevents pregnancy 95% of the time when placed within 72 hours of having unprotected sex. 

The copper IUD does not contain hormones at all. Instead, the copper IUD acts as a barrier after it is inserted into the uterus. Copper is naturally toxic to sperm and eggs, preventing pregnancy. Once the copper IUD is in place, it can remain in the uterus as a birth control device for up to 10 years. After the copper IUD is removed, fertility returns to normal within a week. 

Sources: Planned Parenthood, Contraception, Mayo Clinic

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
NOV 17, 2022
Neuroscience
Fluorescent Proteins Extend Blood Flow Tracking to Months in Mice
NOV 17, 2022
Fluorescent Proteins Extend Blood Flow Tracking to Months in Mice
Harmless, fluorescent proteins allow scientists to track blood flow in mice. The advance could help researchers monitor ...
NOV 22, 2022
Clinical & Molecular DX
Women With Benign Breast Diseases, Including Cysts and Fibroadenomas, Face Higher Risk of Breast Cancer
NOV 22, 2022
Women With Benign Breast Diseases, Including Cysts and Fibroadenomas, Face Higher Risk of Breast Cancer
Though they are very common, benign breast diseases may indicate an increased likelihood of developing breast cancer at ...
NOV 23, 2022
Drug Discovery & Development
Nanoneedles for Ocular Drug Delivery
NOV 23, 2022
Nanoneedles for Ocular Drug Delivery
The eye is a readily available part of the human body, yet drug delivery there is incredibly difficult. Most ocular drug ...
NOV 29, 2022
Cell & Molecular Biology
How a Master Regulator May be Working to Protect Cancer
NOV 29, 2022
How a Master Regulator May be Working to Protect Cancer
Scientists have now discovered yet another way that MYC proteins can promote cancer. MYC has been called a master regula ...
DEC 03, 2022
Neuroscience
Promising Epilepsy Treatment Suppresses Neuroinflammation
DEC 03, 2022
Promising Epilepsy Treatment Suppresses Neuroinflammation
A team of City University of Hong Kong (CityU) neuroscientists recently identified and developed a new drug candidate fo ...
DEC 05, 2022
Health & Medicine
FDA Approves the First Drug Made From the Fecal Microbiome
DEC 05, 2022
FDA Approves the First Drug Made From the Fecal Microbiome
The gastrointestinal tract is home to trillions of microbes, many of which have a crucial role in our health. Now the US ...
Loading Comments...